Januario E Castro MD

PubMed

• 1 citations
  Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study.
  Paolo Strati, Januario Castro, Aaron Goodman, Veronika Bachanova, Manali Kamdar
  The Lancet. Haematology. 2025-07-01
• Impact of granulocyte colony-stimulating factor on safety of chimeric antigen receptor-T-cell therapy in non-Hodgkin lymphoma.
  Kevin Chung, Lay She Ng, Claire I Yee, Radhika Bansal, Mohamed A Kharfan-Dabaja
  British Journal of Haematology. 2025-06-17
• Cellular therapies in rheumatic and musculoskeletal diseases.
  Pedro Franco-Fuquen, Juana Figueroa-Aguirre, David A Martínez, Eider F Moreno-Cortes, Juan E Garcia-Robledo
  Journal of Translational Autoimmunity. 2025-06-01

Journal Articles

• Development of allogeneic hematopoietic stem cell transplantation (HSCT) (Chapter Review)  
  Castro JE, Ball ED, Cancer Treat Res, 1/1/2002
• Nesidioblastosis: Report of the fist adult cases in Colombia  
  Castro JE, Delgado JC, Landazabal G, Rev Col Cirugia, 1/1/1994
• Enriched potassium diet for the treatment of mild hypertension  
  Balaguera HU, Castro JE, Corzo D, Delgado JC, Gamarra G, Acta Medica Colombiana, 1/1/1992
• Primary brain neoplasm: Current concepts and case presentation  
  Saavedra CH, Castro JE, Medicas UIS, 1/1/1991
• Perinatal AIDS Review and case presentation in Santander  
  Castro JE, Delgado JC, Gonzalez HL, Medicas UIS, 1/1/1990
• Anemia: Do we know far enough?  
  Castro JE, Medicas UIS, 1/1/1989
• Join now to see all

Books/Book Chapters

• Cancer Growth and Progression, Vol. 13, Cancer Management in Man: Biological Therapy, Hyperthermia and Supporting Measures. 
  Chapter: Current Status of Bone Marrow Transplantation for Treatment of Cancer. Chapter 23 
  Page 407 - 436Ball, E.D., Bashey, A., Carrier, E., Castro, J.E., Holman, P. and Lane, T.Editors: Volume Editor: Minev, B., Series Editor: Kaiser, H.E..2011
• Williams Hematology. 
  Chapter: Gene therapy for Hematological Malignancies. 
  Page 392 - 399Castro JE, Kipps TJMcGraw Hill, New York, NY2010
• Chronic Lymphocytic Leukemia, molecular genetics, biology, diagnosis and management. 
  Chapter: Gene therapy of chronic lymphocytic leukemia. 
  Page 329 - 342Castro JE, Kipps TJEditors: Guy Faget.Humana Press, Totowa, NJ2004
• Neoplastic Diseases of the Blood. 
  Chapter: Genetic Factors in Lymphomagenesis. 
  Page 662 - 672Castro JE, Kipps TJEditors: Peter H. Wiernik, John M. Goldman, Janice P. Dutcher, Robert A. Kyle.Cambridge University Press2004
• Join now to see all

Lectures

• A Phase Ib/II Study of Ibrutinib in Combination with Obinutuzumab-Gazyva As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia > 65 Years Old or with ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Ibrutinib Reduces Obinutuzumab-Gazyva Infusion Related Reactions (IRR) in Patients with Chronic Lymphocytic Leukemia (CLL) and It Is Associated with Changes on Plasma ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Ibrutinib Reduces Obinutuzumab-Gazyva Infusion Related Reactions (IRR) in Patients with Chronic Lymphocytic Leukemia (CLL) and It Is Associated with Changes on Plasma ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

• Clinical Review various topics in Hematology and Oncology. 
  Castro JE, PDxMED - Online Medical Review, Elsevier Science
  http://www.firstconsult.com
  London, UK - 1/1/2004